MiMedx Group Statistics
Total Valuation
MiMedx Group has a market cap or net worth of $1.34 billion. The enterprise value is $1.27 billion.
Important Dates
The last earnings date was Wednesday, October 30, 2024, after market close.
| Earnings Date | Oct 30, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
MiMedx Group has 146.95 million shares outstanding. The number of shares has increased by 47.75% in one year.
| Current Share Class | 146.95M |
| Shares Outstanding | 146.95M |
| Shares Change (YoY) | +47.75% |
| Shares Change (QoQ) | -0.35% |
| Owned by Insiders (%) | 1.42% |
| Owned by Institutions (%) | 42.79% |
| Float | 108.98M |
Valuation Ratios
The trailing PE ratio is 18.08 and the forward PE ratio is 31.11.
| PE Ratio | 18.08 |
| Forward PE | 31.11 |
| PS Ratio | 3.72 |
| Forward PS | 3.59 |
| PB Ratio | 7.39 |
| P/TBV Ratio | 8.89 |
| P/FCF Ratio | 23.95 |
| P/OCF Ratio | 23.19 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 18.77, with an EV/FCF ratio of 22.70.
| EV / Earnings | 15.46 |
| EV / Sales | 3.70 |
| EV / EBITDA | 18.77 |
| EV / EBIT | 19.91 |
| EV / FCF | 22.70 |
Financial Position
The company has a current ratio of 4.10, with a Debt / Equity ratio of 0.11.
| Current Ratio | 4.10 |
| Quick Ratio | 3.41 |
| Debt / Equity | 0.11 |
| Debt / EBITDA | 0.28 |
| Debt / FCF | 0.34 |
| Interest Coverage | 19.66 |
Financial Efficiency
Return on equity (ROE) is 62.47% and return on invested capital (ROIC) is 23.08%.
| Return on Equity (ROE) | 62.47% |
| Return on Assets (ROA) | 18.38% |
| Return on Capital (ROIC) | 23.08% |
| Revenue Per Employee | $383,021 |
| Profits Per Employee | $91,619 |
| Employee Count | 895 |
| Asset Turnover | 1.58 |
| Inventory Turnover | 2.63 |
Taxes
| Income Tax | -25.89M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -0.44% in the last 52 weeks. The beta is 1.98, so MiMedx Group's price volatility has been higher than the market average.
| Beta (5Y) | 1.98 |
| 52-Week Price Change | -0.44% |
| 50-Day Moving Average | 7.93 |
| 200-Day Moving Average | 7.14 |
| Relative Strength Index (RSI) | 53.38 |
| Average Volume (20 Days) | 814,813 |
Short Selling Information
The latest short interest is 3.42 million, so 2.33% of the outstanding shares have been sold short.
| Short Interest | 3.42M |
| Short Previous Month | 3.52M |
| Short % of Shares Out | 2.33% |
| Short % of Float | 3.14% |
| Short Ratio (days to cover) | 3.07 |
Income Statement
In the last 12 months, MiMedx Group had revenue of $342.80 million and earned $82.00 million in profits. Earnings per share was $0.52.
| Revenue | 342.80M |
| Gross Profit | 285.80M |
| Operating Income | 63.65M |
| Pretax Income | 63.47M |
| Net Income | 82.00M |
| EBITDA | 67.51M |
| EBIT | 63.65M |
| Earnings Per Share (EPS) | $0.52 |
Full Income StatementBalance Sheet
The company has $88.80 million in cash and $19.02 million in debt, giving a net cash position of $69.78 million or $0.47 per share.
| Cash & Cash Equivalents | 88.80M |
| Total Debt | 19.02M |
| Net Cash | 69.78M |
| Net Cash Per Share | $0.47 |
| Equity (Book Value) | 181.01M |
| Book Value Per Share | 1.23 |
| Working Capital | 130.20M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $57.67 million and capital expenditures -$1.85 million, giving a free cash flow of $55.83 million.
| Operating Cash Flow | 57.67M |
| Capital Expenditures | -1.85M |
| Free Cash Flow | 55.83M |
| FCF Per Share | $0.38 |
Full Cash Flow StatementMargins
Gross margin is 83.37%, with operating and profit margins of 18.57% and 25.80%.
| Gross Margin | 83.37% |
| Operating Margin | 18.57% |
| Pretax Margin | 17.49% |
| Profit Margin | 25.80% |
| EBITDA Margin | 19.69% |
| EBIT Margin | 18.57% |
| FCF Margin | 16.29% |
Dividends & Yields
MiMedx Group does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -47.75% |
| Shareholder Yield | -47.75% |
| Earnings Yield | 6.13% |
| FCF Yield | 4.17% |
Analyst Forecast
The average price target for MiMedx Group is $12.00, which is 31.87% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $12.00 |
| Price Target Difference | 31.87% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (5Y) | 10.61% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
MiMedx Group has an Altman Z-Score of 11.61 and a Piotroski F-Score of 6.
| Altman Z-Score | 11.61 |
| Piotroski F-Score | 6 |